Recombinant DNA Technology Flashcards

Topic = Recombinant DNA Technology

Foundations of Biotechnology and Genetic Engineering

  • Definition of Biotechnology: A field of applied biology involving the use of living organisms and bioprocesses in engineering, technology, medicine, and other sectors.

  • Historical Context:

    • Microorganisms have been used for centuries in the production of wine and cheese.

    • Selective breeding of livestock has orignated as an early form of biotechnology.

    • Grafting of fruit plants is a historical practical application.

  • Genetic Engineering Definition: The direct manipulation of genes for practical purposes, specifically the alteration of the genetic constitution of cells or organisms through selective modification, insertion, or deletion of individual genes.

  • Recombinant DNA Definition: Molecules of DNA where genes from two different sources (often different species) are combined in vitro (in a test tube) into the same molecule.

  • Gene Cloning (Molecular Cloning): The production of many identical copies of a DNA molecule (or a portion of it) via replication in a suitable host such as bacteria. It is explicitly distinguished from whole animal cloning.

Core Tools and Components of Recombinant DNA Technology

  • Restriction Enzymes:

    • Function: These enzymes cut DNA at specific locations.

    • Mechanism: They recognize specific nucleotide sequences known as the "recognition site."

    • Variety: There are over 600600 known enzymes for more than 200200 recognition sites.

    • Natural Purpose: Occur naturally in bacteria to cut foreign DNA, protecting the bacteria from viruses or other bacteria.

    • Result: Some enzymes create "sticky ends," which are short, single-stranded overhangs.

  • Cloning Vectors (Plasmids):

    • Definition: Small, circular DNA molecules separate from the bacterial chromosome.

    • Function: Act as delivery vehicles to introduce a gene of interest into a host cell.

    • Markers: Often contain antibiotic resistance genes and other markers (e.g., lacZ) to assist in identifying successful clones.

  • DNA Ligase:

    • Function: An enzyme that fuses two pieces of DNA together (e.g., the plasmid and the gene of interest) to create a single recombinant DNA molecule.

  • Host Cells:

    • Primary Choice: Bacteria (specifically E. coli) are most commonly used because they are easy to isolate, have circular DNA, and reproduce rapidly.

    • Growth Rates: E. coli cells can replicate every 2020 minutes.

    • Other Systems: Yeast cells, insect cells, and mammalian cells (via tissue culture) are also used.

Procedural Steps in Gene Cloning

  1. Cutting DNA: Both the target DNA and the cloning vector (plasmid) are cut using the same restriction enzyme.

  2. Ligation: DNA fragments and modification enzymes (DNA ligase) are mixed. The fragments cut with the same enzyme will base-pair at their sticky ends, and ligase will seal the sugar-phosphate backbone.

  3. Bacterial Transformation: The recombinant plasmid is introduced into host cells.

  4. Identification (Screening): Methods are used to identify which bacterial clones have successfully taken up the desired recombinant DNA.

Bacterial Transformation and Selection Methods

  • Transformation: The process of transferring exogenous (foreign) DNA into cells.

  • Chemical Method: Involves treating cells with Calcium Chloride (CaCl2CaCl_2), chilling on ice, and applying a Heat Shock at 42∘C42^\circ\text{C} to promote DNA entry.

  • Electroporation: Utilizing a short pulse of electric charge to create micropores in the cell membrane, allowing DNA to enter before the membrane reseals.

  • Screening with Plasmid Constructs:

    • amp: Confers resistance to the antibiotic ampicillin. Only bacteria that take up the plasmid survive on ampicillin-containing agar.

    • lacZ: Encodes the enzyme β\beta-galactosidase, which hydrolyzes sugars.

    • Blue/White Screening:

      • The foreign DNA is inserted into the lacZ gene, disrupting it.

      • Bacterial colonies are grown on agar with ampicillin and a β\beta-galactosidase substrate called X-gal.

      • Blue Colonies: Bacteria that hydrolyze X-gal (no insert disruption) produce indigo and turn blue.

      • White Colonies: Bacteria that cannot hydrolyze X-gal (gene disrupted by target insert) remain white; these are the desired recombinant clones.

  • Alternative Screening: Colony PCR is often used today as it is faster and cheaper than traditional restriction enzyme digests.

  • Validation: DNA sequencing is used to ensure the correct DNA was inserted. Screening for protein production can include Cell Lysate tests by Western Blot or ELISA.

Medical Applications of Recombinant DNA Technology

  • Pharmaceutical Production: Used to produce human proteins like growth hormone, interferon, and clotting factor VIII.

  • Human Insulin (Humulin):

    • Traditionally obtained from bovine (cow) or porcine (pig) sources, which caused immune reactions in some patients.

    • Recombinant Process: The human insulin gene is cut with restriction enzymes, inserted into an E. coli plasmid, and replicated in bacteria. The protein is then purified.

    • Benefit: Humulin is chemically identical to human insulin and provides a sustainable supply.

  • Vaccines:

    • Development of vaccines by cloning protective antigen proteins.

    • Examples: Human Papilloma Virus (HPV), Influenza, and Hepatitis B.

    • Virus-like Particles (VLPs): Empty viral capsids produced by the L1 gene with no viral DNA inside, used as safe vaccines.

  • Diagnosis and Forensic Science:

    • PCR and labeled probes track pathogens (e.g., detecting viral DNA in blood samples).

    • Identification of individuals with genetic diseases before onset (e.g., hemophilia, cystic fibrosis, and Duchenne muscular dystrophy).

    • Identification of symptomless carriers.

  • Gene Therapy:

    • Targeting bone marrow cells (which produce blood and immune cells).

    • A normal allele is inserted into a viral vector and introduced into the patient's removed bone marrow cells.

    • Challenges: Activity of genes often diminishes over time; limited evidence of long-term effectiveness to date.

Specialized Case Study: Duchenne Muscular Dystrophy (DMD)

  • Mutation: Exon 5151 cannot join with Exon 5353, preventing the assembly of the rest of the protein, leading to a non-functional dystrophin protein.

  • Exondys 51: A drug that acts as a "molecular plaster" to skip the problematic dystrophin gene segment.

  • Mechanism: It allows Exon 5151 to join up to Exon 5454, skipping exons 5252 and 5353. This produces a shorter but functional protein, mitigating severe symptoms.

Agricultural and Environmental Applications

  • Agriculture:

    • Ti Plasmid: Derived from Agrobacterium, utilized as a vector to infect plant cells with desirable genes.

    • Transgenic Plants: Resistance to pesticides, herbicides (e.g., cotton), and disease. Delayed ripening to resist spoilage.

    • Nutritional Improvement: "Golden Rice" contains β\beta-carotene, a precursor to Vitamin A.

  • Environmental Biotechnology:

    • Generating "oil-eaters" (microbes for remediation/toxic waste cleanup).

    • Engineering bacteria that can produce proteins to help snow form at higher temperatures.

Advanced Gene Editing: CRISPR-Cas9

  • Components:

    • Guide RNA: Binds to a specific target DNA sequence.

    • Cas9 Enzyme: Binds to the guide RNA.

    • Mechanism: The Cas9 enzyme cuts both strands of the DNA. The cell repairs the cut, which can introduce a specific mutation or correction.

Ethical, Safety, and Social Considerations

  • Safety Concerns: Potential for creating hazardous new pathogens that are antibiotic-resistant.

  • Genetically Modified (GM) Organisms: Public concern regarding hazards to human health or ecological harm.

  • Regulatory Environment: Europe has seen pending legislation and bans on the import of GM foodstuffs despite limited data proving specific health risks.

  • Social/Legal issues: Concerns regarding the use of huge datasets generated by genetic testing and eligibility for clinical trials.